Related Experiment Video
Updated: Jun 19, 2026
09:26
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Brain-derived neurotrophic factor in patients with normal-tension glaucoma
Alireza Ghaffariyeh1, Nazafarin Honarpisheh, Yadollah Shakiba
1Dr. Khodadoust Eye Hospital, Shiraz, Fars, Iran. alirezaghaffariyeh@hotmail.com
Optometry (St. Louis, Mo.)
|October 29, 2009
Summary
Tear brain-derived neurotrophic factor (BDNF) levels are significantly lower in normal-tension glaucoma (NTG) patients. This finding suggests BDNF may serve as a novel biomarker for early NTG detection.
Area of Science:
- Ophthalmology
- Neuroscience
- Biochemistry
Background:
- Normal-tension glaucoma (NTG) is a progressive optic neuropathy.
- Early detection of NTG is crucial for preventing vision loss.
- Brain-derived neurotrophic factor (BDNF) plays a role in neuronal survival and function.
Purpose of the Study:
- To detect and quantify brain-derived neurotrophic factor (BDNF) in the tears of individuals with and without normal-tension glaucoma (NTG).
- To investigate the potential of tear BDNF as a biomarker for NTG.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure BDNF levels.
- Tear samples were collected from 20 NTG patients and 20 age-matched healthy controls.
- Monoclonal antibodies specific for BDNF were utilized for accurate detection.
Main Results:
- Mean tear BDNF levels were significantly lower in the NTG group (24.33 +/- 1.48 ng/mL) compared to the control group (77.09 +/- 4.84 ng/mL).
- The difference in BDNF levels between the groups was statistically significant (P < 0.001).
Conclusions:
- Tear BDNF levels are markedly reduced in patients with normal-tension glaucoma.
- BDNF in tears shows potential as a non-invasive biochemical marker for the early diagnosis of NTG.
- Further research is warranted to validate tear BDNF as a reliable diagnostic tool for NTG.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...